[{"data":1,"prerenderedAt":150},["ShallowReactive",2],{"drug-oxcarbazepine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":52,"contraindications":113,"warnings":133,"renal":134,"monitoring":135,"interactions":136,"review":137,"examples":140},"oxcarbazepine",1,{"fa":7,"en":8},"اکسکاربازپین","Oxcarbazepine","neurology",{"fa":11,"en":12},"ضدتشنج","Anticonvulsant",[14],{"name":15,"market":16},"Trileptal","US",[18,19,7,20],"trileptal","تری لپتال","اکس کاربازپین",[22,36,44],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-150","tablet","oral","150 mg tablet (scored)",{"amount":28,"unit":29,"perUnit":24,"scored":30},150,"mg",true,[16],[33],{"source":34,"section":35},"fda-oxcarbazepine","3",{"id":37,"form":24,"route":25,"label":38,"concentration":39,"markets":41,"refs":42},"tab-300","300 mg tablet (scored)",{"amount":40,"unit":29,"perUnit":24,"scored":30},300,[16],[43],{"source":34,"section":35},{"id":45,"form":24,"route":25,"label":46,"concentration":47,"markets":49,"refs":50},"tab-600","600 mg tablet (scored)",{"amount":48,"unit":29,"perUnit":24,"scored":30},600,[16],[51],{"source":34,"section":35},[53,84],{"id":54,"disease":55,"label":56,"population":59,"type":63,"unit":29,"dose":64,"refs":70,"notes":75},"adult","epilepsy",{"fa":57,"en":58},"صرع پارشیل — بزرگسال: شروع ۶۰۰ mg\u002Fday در دو نوبت","Partial seizures — adults: start 600 mg\u002Fday in two doses",{"minAge":60},{"value":61,"unit":62},18,"year","titration",{"dividedDoses":65,"titration":66},2,{"start":48,"increment":48,"incrementEveryDays":67,"targetMin":68,"targetMax":69,"max":69},7,1200,2400,[71,73],{"source":34,"section":72},"2.1",{"source":34,"section":74},"2",[76],{"text":77,"refs":80},{"fa":78,"en":79},"کمکی: هدف ۱۲۰۰ mg\u002Fday. تبدیل به تک‌درمانی: هدف ۲۴۰۰ mg\u002Fday. CrCl کمتر از ۳۰: شروع ۳۰۰ mg\u002Fday.","Adjunct: target 1,200 mg\u002Fday. Conversion to monotherapy: target 2,400 mg\u002Fday. CrCl \u003C30: start 300 mg\u002Fday.",[81,82],{"source":34,"section":74},{"source":34,"section":83},"2.7",{"id":85,"disease":55,"label":86,"population":89,"type":94,"unit":29,"dose":95,"refs":98,"limits":101,"notes":104},"peds",{"fa":87,"en":88},"صرع پارشیل — ۴ تا ۱۶ سال: شروع ۸ تا ۱۰ mg\u002Fkg\u002Fday در دو نوبت","Partial seizures — 4–16 y: start 8–10 mg\u002Fkg\u002Fday in two doses",{"minAge":90,"maxAge":92},{"value":91,"unit":62},4,{"value":93,"unit":62},17,"weightBased",{"perKgPerDay":96,"perKgPerDayMax":97,"dividedDoses":65},8,10,[99],{"source":34,"section":100},"2.4",{"maxPerDay":48,"refs":102},[103],{"source":34,"section":100},[105],{"text":106,"refs":109},{"fa":107,"en":108},"شروع معمولاً حداکثر ۶۰۰ mg\u002Fday. نگهدارنده تک‌درمانی بر اساس وزن (جدول ۱).","Start generally not above 600 mg\u002Fday. Monotherapy maintenance by weight (Table 1).",[110,111],{"source":34,"section":100},{"source":34,"section":112},"2.6, Table 1",[114,123],{"id":115,"severity":116,"text":117,"refs":120},"ci","block",{"fa":118,"en":119},"حساسیت به اکسکاربازپین یا اسلی‌کاربازپین.","Hypersensitivity to oxcarbazepine or eslicarbazepine.",[121],{"source":34,"section":122},"4",{"id":124,"severity":116,"rule":125,"text":127,"refs":130},"under-2",{"maxAge":126},{"value":65,"unit":62},{"fa":128,"en":129},"زیر ۲ سال ثابت نشده.","Not established under 2 years.",[131],{"source":34,"section":132},"8.4",[],[],[],[],{"status":138,"reviewer":139,"date":139},"unverified",null,[141,146],{"regimen":54,"formulation":37,"input":142,"expect":145},{"ageYears":143,"weightKg":144},30,70,{"perDose":40},{"regimen":85,"formulation":23,"input":147,"expect":149},{"ageYears":97,"weightKg":148},37.5,{"perDose":28,"tabletsPerDoseRounded":5},1792078539179]